巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Intra-Cellular Therapies

    ITCI
    48.710
    0.970
    2.03%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Intra-Cellular Therapies - 延遲價格・最後更新於 04/10 12:00
    最高位
    48.940
    最低位
    47.740
    開市價
    --
    前收市價
    47.740
    成交量(千)
    15.03
    成交額(百萬)
    6.85
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    4,598.31
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    66.000 - 34.430
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Intra-Cellular Therapies
    證券代碼
    ITCI.US
    所屬板塊
    Drug Manufacturers - Specialty & Generic
    公司業務
    Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
    發行量
    94324313
    公司總部
    430 East 29th Street
    公司網址
    https://www.intracellulartherapies.com
    公司電郵
    ir@intracellulartherapies.com
    公司電話
    +1 646 440-9333

    再漲155%?機構押注這些生物科技股今年勢將「逆襲」

    美股情報局·
    再漲155%?機構押注這些生物科技股今年勢將「逆襲」

    關於

    Intra-Cellular Therapies(ITCI.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
    Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
    詳細公司背景可參考: https://www.intracellulartherapies.com